26.01.2015 • NewsClariantstrategic allianceBeraca

Clariant to Establish Strategic Alliance with Beraca

Deepening its footprint in Brazil, Clariant has announced a strategic alliance with Beraca, a leading player in natural, sustainable and innovative ingredients.

Under the terms, the Swiss specialty chemicals producer will acquire a 30% share of the Brazilian company's Health and Personal Care division, with a provision to increase its shareholding at a later date.

Michael Willome, head of Clariant's Industrial & Consumer Specialties business unit, said the deal - still subject to certain conditions precedent, as well as regulatory approvals - will enhance his company's innovation capabilities in the field of natural ingredients for cosmetics and personal care applications and "enlarge the range of valuable solutions" it can offer.

"Beraca is a key cornerstone in enhancing Clariant's portfolio with regard to natural ingredients, biological active extracts and natural emollients," Manlio Gallotti, head of Clariant's ICS Latin America, added.

Tapping Clariant's "extensive technological expertise" in chemistry and cosmetics' applications "will be essential to upgrade Beraca's portfolio and bring it to new geographies," said Beraca president Ulisses Sabara.

Whitepaper

Cannabis Extraction — Temperature Control Systems in Action

Cannabis Extraction — Temperature Control Systems in Action

Cannabis is a crop that has been cultivated for thousands of years and contains many pharmacologically active substances.

Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.